Quantitative phase imaging in biomedicine

Phi Optics CEO Dr. Gabriel Popescu recently collaborated with other Quantitative Phase Imaging (QPI) pioneers to show how QPI has emerged from development in the lab to relevant commercial applications in biomedicine. New applications include cell biology, neuroscience, cell tomography, cancer diagnosis and more. Their research was published in Nature Photonics volume 12, pages 578–589 (2018).

Phi Optics is pleased to be at the forefront of QPI. We have label-free, quantitative solutions for a variety of imaging challenges and workflows. Please contact us for more information about how our imaging systems can help with your research and development: info@phioptics.com